[1]侯拂晓.四联疗法治疗幽门螺旋杆菌相关性十二指肠球炎疗效分析[J].医学信息,2018,(17):135-136.[doi:10.3969/j.issn.1006-1959.2018.17.042]
 HOU Fu-xiao.Therapeutic Effect of Quadruple Therapy on Helicobacter pylori Associated Duodenal Inflammation[J].Medical Information,2018,(17):135-136.[doi:10.3969/j.issn.1006-1959.2018.17.042]
点击复制

四联疗法治疗幽门螺旋杆菌相关性十二指肠球炎疗效分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年17期
页码:
135-136
栏目:
药物与临床
出版日期:
2018-09-01

文章信息/Info

Title:
Therapeutic Effect of Quadruple Therapy on Helicobacter pylori Associated Duodenal Inflammation
文章编号:
1006-1959(2018)17-0135-02
作者:
侯拂晓
武汉大学医院内科,湖北 武汉 430000
Author(s):
HOU Fu-xiao
Department of Internal Medicine,Wuhan University Hospital,Wuhan 430000,Hubei,China
关键词:
幽门螺旋杆菌十二指肠球炎四联疗法三联疗法
Keywords:
Key words:Helicobacter pyloriDuodenal inflammationQuadruple therapyTriple therapy
分类号:
R574.51
DOI:
10.3969/j.issn.1006-1959.2018.17.042
文献标志码:
A
摘要:
目的 比较标准四联与三联法治疗幽门螺旋杆菌相关性十二指肠球炎临床疗效。方法 选择2017年5月~2018年5月我院收治的幽门螺旋杆菌相关性十二指肠球炎患者96例,随机分为观察组和对照组,每组48例。观察组采用兰索拉唑、克拉霉素、阿莫西林、果胶铋标准四联治疗,对照组采用兰索拉唑、克拉霉素、阿莫西林标准三联治疗。比较两组患者Hp根除率、复发率及不良反应情况。结果 观察组患者Hp根除率为91.67%,高于对照组75.00%,差异具有统计学意义(P<0.05)。观察组患者Hp复发率为10.42%,低于对照组的20.83%,差异具有统计学意义(P<0.05)。观察组不良反应发生率为4.16%,低于对照组的6.25%,但组间比较,差异无统计学意义(P>0.05)。结论 标准四联疗法治疗幽门螺旋杆菌相关性十二指肠球炎,Hp根除率较高,复发率低,且不增加不良反应发生率。
Abstract:
Abstract:Objective To compare the clinical efficacy of standard quadruple therapy and triple therapy in the treatment of Helicobacter pylori associated duodenal inflammation.Methods 96 patients with Helicobacter pylori associated duodenal inflammation admitted to our hospital from May 2017 to May 2018 were randomly divided into observation group and control group,48 cases in each group.The observation group was treated with lansoprazole,clarithromycin,amoxicillin and bismuth pectin standard quadruple therapy,while the control group was treated with lansoprazole,clarithromycin and amoxicillin standard triple therapy.Hp eradication rate,relapse rate and adverse reactions were compared between the two groups.Results The Hp eradication rate of the observation group was 91.67%,which was higher than that of the control group 75.00%,the difference was statistically significant(P<0.05).The recurrence rate of Hp in the observation group was 10.42%,which was lower than that in the control group 20.83%,the difference was statistically significant (P<0.05).The incidence of adverse reactions in the observation group was 4.16%,which was lower than 6.25% in the control group,but there was no significant difference between the groups(P>0.05).Conclusion Standard quadruple therapy for Helicobacter pylori associated duodenal inflammation has a high eradication rate,a low recurrence rate and no increase in the incidence of adverse reactions.

参考文献/References:

[1]康晓芳.幽门螺旋杆菌感染与慢性胃炎的相关性分析[J].中国医药指南,2017,15(3):39-40. [2]王淑君,王蔚虹,褚云香,等.铋剂四联疗法与标准三联疗法根除幽门螺杆菌的效果分析[J].中华医学杂志,2014,94(8):576-579. [3]刘文忠.幽门螺杆菌胃炎京都全球共识解读[J].胃肠病学,2015,20(8):449-455. [4]周本刚,郭鹏,肖政,等.幽门螺杆菌感染与胃息肉关系的Meta分析[J].山东医药,2015,59(44):11-14. [5]杨成,崔梅花.幽门螺杆菌致病因子及其致病机制研究进展[J].世界华人消化杂志,2017,25(10):857-864. [6]张芝华,张志广,李熳,等.4种含铋剂四联方案根除幽门螺杆菌的临床观察[J].天津医科大学学报,2016,22(1):41-43. [7]刘文忠,谢勇,成虹,等.第四次全国幽门螺杆菌感染处理共识报告[J].胃肠病学,2012,17(10):618-625.

相似文献/References:

[1]邱梦君,郑国荣.大黄、黄连、黄芩联合三联序贯治疗Hp感染的疗效分析[J].医学信息,2018,(06):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
 QIU Meng-jun,ZHENG Guo-rong.Curative Effect Analysis of Sequential Treatment of Hp Infection by Rhubarb,Coptis Chinensis and Radix Scutellariae[J].Medical Information,2018,(17):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
[2]夏 铭,张正坤,曾海龙,等.四种疗法治疗幽门螺杆菌阳性消化性溃疡疗效分析[J].医学信息,2018,(11):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]
 XIA Ming,ZHANG Zheng-kun,ZENG Hai-long,et al.Therapeutic Effect of Four Kinds of Therapy on Helicobacter Pylori Positive Peptic Ulcer[J].Medical Information,2018,(17):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]

更新日期/Last Update: 2018-09-01